文献速递胰腺与胆道疾病消化内镜消化道肿瘤与早癌

EUS引导下肝胃吻合术与联合顺行支架置入术在不可切除恶性远端胆道梗阻中的倾向评分匹配病例对照研究

EUS-guided hepaticogastrostomy versus EUS-guided hepaticogastrostomy with antegrade stent placement in patients with unresectable malignant distal biliary obstruction: a propensity score-matched case-control study.
PubMed 文献 · Gastrointest Endosc · 2024-02-19

本研究回顾性比较了EUS引导下肝胃吻合术(EUS-HGS)与联合顺行支架置入的EUS-HGS(EUS-HGAS)在不可切除恶性远端胆道梗阻患者中的结局。

核心结论

  • EUS-HGAS较EUS-HGS延长了TRBO,但除RBO外的不良事件及总生存无差异。
  • EUS-HGAS较长的TRBO可能使预期寿命较长的患者获益。

研究设计与样本

  • 回顾性分析2014年1月至2020年12月5家机构连续接受EUS-HGS或EUS-HGAS的恶性远端胆道梗阻患者。
  • 共360例患者,283例符合条件(HGS组176例,HGAS组107例),经1:1倾向评分匹配后每组81例。
  • 主要结局为TRBO,次要结局为除RBO外的不良事件和总生存。

临床怎么用

  • 对于不可切除恶性远端胆道梗阻且预期寿命较长的患者,可考虑EUS-HGAS以延长支架通畅时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: EUS-guided hepaticogastrostomy (EUS-HGS) is a rescue procedure when ERCP fails. Peritonitis and recurrent biliary obstruction (RBO) are adverse events (AEs) associated with EUS-HGS. Antegrade stent placement across a malignant distal biliary obstruction (DBO) followed by EUS-HGS (EUS-HGAS) creates 2 biliary drainage routes, potentially reducing peritonitis and prolonging time to RBO (TRBO). We compared the outcomes of the 2 techniques. METHODS: Data of consecutive patients with malignant DBO who underwent attempted EUS-HGS or EUS-HGAS across 5 institutions from January 2014 to December 2020 were retrospectively analyzed. A matched cohort of patients was obtained using 1-to-1 propensity score matching. The primary outcome was TRBO, and secondary outcomes were AEs except for RBO and overall survival. RESULTS: Among 360 patients, 283 (176 and 107 in the HGS and HGAS groups, respectively) were eligible. The matched cohorts included 81 patients in each group. AEs developed in 10 (12.3%) and 15 (18.5%) patients (P = .38) in the HGS and HGAS groups, respectively. RBO occurred in 18 and 2 patients in the HGS and HGAS groups, respectively (P < .001). TRBO was significantly longer in the HGAS group (median, 194 days vs 716 days; hazard ratio, .050; 95% confidence interval, .0066-.37; P < .01). However, no significant differences occurred in overall survival between the groups (median, 97 days vs 112 days; hazard ratio, .97; 95% confidence interval, .66-1.4; P = .88). CONCLUSIONS: EUS-HGAS extended TRBO compared with EUS-HGS, whereas AEs, except for RBO and overall survival, did not differ. The longer TRBO of EUS-HGAS could benefit patients with longer life expectancy.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Ishiwatari H, Ogura T, Hijioka S, et al. EUS-guided hepaticogastrostomy versus EUS-guided hepaticogastrostomy with antegrade stent placement in patients with unresectable malignant distal biliary obstruction: a propensity score-matched case-control study. Gastrointest Endosc. 2024. PMID: 38382887. doi:10.1016/j.gie.2024.02.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。